Sandoz Biopharma Head Levick To Become CEO Of Alvotech

 
• By Dave Wallace

Mark Levick, Sandoz’ head of development for biopharmaceuticals, has been chosen to become CEO of Alvotech from August.

CEO
Alvotech Has Looked To Sandoz To Find Its New CEO • Source: Shutterstock

More from Leadership

More from Generics Bulletin